Uncover key drivers, emerging technologies, and competitive movements shaping the neuro immunoassay market from 2026–2035 with trusted insights from The Business Research Company
What upper market value could the Neuro Immunoassay Market reach by 2030 starting from 2026 levels?
The market size for neuro immunoassay (NIA) has demonstrated strong expansion in recent years. It is anticipated to increase from $2.88 billion in 2025 to $3.12 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.5%. This historic market expansion is primarily due to several factors: a heightened demand for sensitive neurological diagnostic methods, the increasing integration of immunoassay techniques into neuroscience research, the growing occurrence of neurodegenerative conditions, the proliferation of clinical and research laboratories, and an intensified focus on early disease detection and ongoing monitoring.
The neuro immunoassay (NIA) market is anticipated to experience substantial expansion over the coming years. This market is projected to reach **$4.28 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 8.2%**. This projected increase during the forecast period can be attributed to several factors, including the increasing integration of neuro immunoassay (NIA) with artificial intelligence (AI) for data analysis, growing investments in biomarker discovery, the expanding use of personalized medicine and therapeutic monitoring, the proliferation of high-throughput screening platforms, and a heightened demand for automated and accurate immunoassay systems. Key developments expected during this period involve technological innovations enhancing assay sensitivity and specificity, progress in AI-powered data interpretation, advancements in multiplexed and lab-on-a-chip immunoassay systems, intensified research and development efforts in identifying neuro biomarkers, and novel integrated and automated neurodiagnostic platforms.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30676&type=smp
Which Drivers Are Influencing Long-Term Growth In The Neuro Immunoassay Market?
The future expansion of the neuro immunoassay market is anticipated to be driven by the rising occurrence of neurological disorders. These disorders are medical conditions impacting the brain, spinal cord, and nerves, which interferes with typical nervous system operations, causing deficits in movement, thought processes, sensory perception, conduct, or general bodily regulation. The growing incidence of neurological conditions stems from unhealthy lifestyle choices, such as inadequate nutrition, lack of physical activity, smoking, heavy drinking, and persistent stress. Neuro immunoassays facilitate the identification of particular biomarkers within the nervous system, thereby aiding in the timely diagnosis and precise treatment of individuals with neurological conditions. As an illustration, data from April 2024 released by the National Institutes of Health (NIH), a US government entity, indicates that approximately 6.9 million Americans aged 65 and above are presently suffering from Alzheimer’s dementia, a number expected to almost double to 13.8 million by 2060. Consequently, the escalating occurrence of neurological conditions is a key factor propelling the neuro immunoassay market.
How Is The Neuro Immunoassay Market Divided Into Segments?
The neuro immunoassay market covered in this report is segmented –
1) By Product Type: Reagents And Kits, Analyzers
2) By Technology: Radioimmunoassays (RIA), Polymerase Chain Reaction (PCR), Enzyme-Linked Immunosorbent Assay (ELISA), Western Blot, Rapid Tests, Enzyme-Linked Immunospot Assay (ELISPOT)
3) By Analyte Or Biomarker Type: Amyloid-Beta (Aß), Tau Protein (p-Tau), Alpha-Synuclein (a-syn), Neurofilament Light Chain (NfL), Autoantibodies, Cytokines, Glial Fibrillary Acidic Protein (GFAP), Neuron-Specific Enolase (NSE), Ubiquitin C-Terminal Hydrolase L1 (UCH-L1), Brain-Derived Neurotrophic Factor (BDNF)
4) By Application: Alzheimer’s Disease, Parkinson’s Disease (PD), Huntington’s Disease, Amyotrophic Lateral Sclerosis (ALS), Spinal Muscular Atrophy (SMA)
5) By End-User: Hospitals, Clinics, Academic Organizations, Biopharmaceutical Companies, Pharmaceutical Companies, Other End-Users
Subsegments:
1) By Reagents And Kits: Enzyme Linked Immunosorbent Assay Reagents, Western Blotting Kits, Multiplex Assay Kits
2) By Analyzers: Automated Immunoassay Analysers, Point Of Care Immunoassay Analysers, High Throughput Immunoassay Analysers
What Trends Are Driving The Growth Trajectory Of The Neuro Immunoassay Market?
Leading companies in the neuro immunoassay market are concentrating on developing sophisticated solutions, such as blood-based neurological biomarker assays, to enhance disease monitoring, improve prognostic accuracy, and support clinical decision-making in neurological disorders. Blood-based neurological biomarker assays refer to tests that quantify specific proteins, including Neurofilament Light Chain (NfL), in human serum or plasma to assess neuronal injury and disease activity. For example, in June 2024, Siemens Healthineers, a Germany-based in vitro diagnostics company, secured CE marking for its Neurofilament Light Chain blood test, which is designed for operation on the Atellica IM Analyzer and ADVIA Centaur systems. This test measures NfL levels to assist in predicting the risk of neuronal injury in adults with relapsing multiple sclerosis, serving as an adjunct to clinical, imaging, and laboratory assessments, and the CE mark signifies adherence to European In Vitro Diagnostic Regulations, thereby expanding access to standardized neuro immunoassay diagnostics across European laboratories.
Which Major Industry Participants Are Leading The Neuro Immunoassay Market Growth?
Major companies operating in the neuro immunoassay market are Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories Inc., GenScript Biotech Corporation, Abcam plc, BioLegend Inc., Meso Scale Diagnostics LLC, Sino Biological Inc., Quanterix Corporation, Cusabio Technology LLC, OriGene Technologies Inc., Elabscience Biotechnology Inc., RayBiotech Life Inc., Enzo Life Sciences Inc., Rockland Immunochemicals Inc., Assay Genie Ltd., Novus Biologicals LLC, Creative Diagnostics, MyBioSource Inc., Immuno-Biological Laboratories Co. Ltd., Boster Biological Technology, Cloud-Clone Corp., FineTest Biotech Inc., Abbexa Ltd.
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/neuro-immunoassay-market-report
Which Region Is Expected To Experience The Fastest Growth In The Neuro Immunoassay Market?
North America was the largest region in the neuro immunoassay (NIA) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuro immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Neuro Immunoassay Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=30676&type=smp
Browse Through More Reports Similar to the Global Neuro Immunoassay Market 2026, By The Business Research Company
Immunoassay Market Report 2026
https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report
Immunohematology Market Report 2026
https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report
immunomodulator global market report
https://www.thebusinessresearchcompany.com/report/immunomodulator-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model